Advertisement
Singapore markets closed
  • Straits Times Index

    3,224.01
    -27.70 (-0.85%)
     
  • Nikkei

    40,168.07
    -594.66 (-1.46%)
     
  • Hang Seng

    16,541.42
    +148.58 (+0.91%)
     
  • FTSE 100

    7,952.62
    +20.64 (+0.26%)
     
  • Bitcoin USD

    70,771.84
    +1,756.59 (+2.55%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • S&P 500

    5,254.35
    +5.86 (+0.11%)
     
  • Dow

    39,807.37
    +47.29 (+0.12%)
     
  • Nasdaq

    16,379.46
    -20.06 (-0.12%)
     
  • Gold

    2,254.80
    +42.10 (+1.90%)
     
  • Crude Oil

    83.11
    +1.76 (+2.16%)
     
  • 10-Yr Bond

    4.2060
    +0.0100 (+0.24%)
     
  • FTSE Bursa Malaysia

    1,530.60
    -7.82 (-0.51%)
     
  • Jakarta Composite Index

    7,288.81
    -21.28 (-0.29%)
     
  • PSE Index

    6,903.53
    +5.36 (+0.08%)
     

Top Ranked Income Stocks to Buy for March 27th

Here are three stocks with buy rank and strong income characteristics for investors to consider today, March 27th:

Algonquin Power & Utilities Corp. (AQN): This owner and operator of utility assets has witnessed the Zacks Consensus Estimate for its current year earnings increasing 4.7% over the last 60 days.

Algonquin Power & Utilities Corp. Price and Consensus

Algonquin Power & Utilities Corp. Price and Consensus
Algonquin Power & Utilities Corp. Price and Consensus

Algonquin Power & Utilities Corp. price-consensus-chart | Algonquin Power & Utilities Corp. Quote

This Zacks Rank #1 (Strong Buy) company has a dividend yield of 4.4%, compared with the industry average of 4.1%. Its five-year average dividend yield is 4.7%.

Algonquin Power & Utilities Corp. Dividend Yield (TTM)

Algonquin Power & Utilities Corp. Dividend Yield (TTM)
Algonquin Power & Utilities Corp. Dividend Yield (TTM)

Algonquin Power & Utilities Corp. dividend-yield-ttm | Algonquin Power & Utilities Corp. Quote

ADVERTISEMENT

AbbVie Inc. (ABBV): This biopharmaceutical company has witnessed the Zacks Consensus Estimate for its current year earnings increasing 2% over the last 60 days.

AbbVie Inc. Price and Consensus

AbbVie Inc. Price and Consensus
AbbVie Inc. Price and Consensus

AbbVie Inc. price-consensus-chart | AbbVie Inc. Quote

This Zacks Rank #2 (Buy) company has a dividend yield of 6.4%, compared with the industry average of 3.6%. Its five-year average dividend yield is 3.4%.

AbbVie Inc. Dividend Yield (TTM)

AbbVie Inc. Dividend Yield (TTM)
AbbVie Inc. Dividend Yield (TTM)

AbbVie Inc. dividend-yield-ttm | AbbVie Inc. Quote

Atlas Corp. (ATCO): This asset manager has witnessed the Zacks Consensus Estimate for its current year earnings increasing 12.6% over the last 60 days.

Seaspan Corporation Price and Consensus

Seaspan Corporation Price and Consensus
Seaspan Corporation Price and Consensus

Seaspan Corporation price-consensus-chart | Seaspan Corporation Quote

This Zacks Rank #2 company has a dividend yield of 5.8%, compared with the industry average of 4.1%. Its five-year average dividend yield is 8.2%.

Seaspan Corporation Dividend Yield (TTM)

Seaspan Corporation Dividend Yield (TTM)
Seaspan Corporation Dividend Yield (TTM)

Seaspan Corporation dividend-yield-ttm | Seaspan Corporation Quote

See the full list of top ranked stocks here.

Find more top income stocks with some of our great premium screens.

The Hottest Tech Mega-Trend of All                

Last year, it generated $24 billion in global revenues. By 2020, it's predicted to blast through the roof to $77.6 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.

See Zacks' 3 Best Stocks to Play This Trend >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Seaspan Corporation (ATCO) : Free Stock Analysis Report
 
Algonquin Power & Utilities Corp. (AQN) : Free Stock Analysis Report
 
AbbVie Inc. (ABBV) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research